RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sorrento Therapeutics Stock

Sorrento Therapeutics Debt 2025

Sorrento Therapeutics Debt

11.8 USD

Ticker

SRNE

ISIN

US83587F2020

WKN

A1W8DY

In 2025, Sorrento Therapeutics's total debt was 11.8 USD, a 0% change from the 0 USD total debt recorded in the previous year.

Sorrento Therapeutics Aktienanalyse

What does Sorrento Therapeutics do?

Sorrento Therapeutics is a biotechnology company based in San Diego, California. It was founded in 2006 by Dr. Henry Ji and specializes in the research and development of biopharmaceuticals, particularly in the field of oncology. Sorrento Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Sorrento Therapeutics's Debt Structure

Sorrento Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Sorrento Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Sorrento Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Sorrento Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Sorrento Therapeutics stock

What is the debt of Sorrento Therapeutics this year?

Sorrento Therapeutics has a debt level of 11.8 USD this year.

What was the debt of Sorrento Therapeutics compared to the previous year?

The debt of Sorrento Therapeutics has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Sorrento Therapeutics?

High debt can pose a risk for investors of Sorrento Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Sorrento Therapeutics?

Low debt means that Sorrento Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Sorrento Therapeutics affect the company?

An increase in debt of Sorrento Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Sorrento Therapeutics affect the company?

A reduction in debt of Sorrento Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Sorrento Therapeutics?

Some factors that can influence the debt of Sorrento Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Sorrento Therapeutics so important for investors?

The debts of Sorrento Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Sorrento Therapeutics take to change the debt?

To change the debt, Sorrento Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Sorrento Therapeutics pay?

Over the past 12 months, Sorrento Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sorrento Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Sorrento Therapeutics?

The current dividend yield of Sorrento Therapeutics is .

When does Sorrento Therapeutics pay dividends?

Sorrento Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sorrento Therapeutics?

Sorrento Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Sorrento Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sorrento Therapeutics located?

Sorrento Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sorrento Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sorrento Therapeutics from 10/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2025.

When did Sorrento Therapeutics pay the last dividend?

The last dividend was paid out on 10/3/2025.

What was the dividend of Sorrento Therapeutics in the year 2024?

In the year 2024, Sorrento Therapeutics distributed 0 USD as dividends.

In which currency does Sorrento Therapeutics pay out the dividend?

The dividends of Sorrento Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sorrento Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Sorrento Therapeutics

Our stock analysis for Sorrento Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sorrento Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.